Dr Reddy’s Laboratories, has launched Amoxicillin tablets Capsules and Oral Suspension, a bioequivalent generic version of Amoxil tablets, capsules and Oral Suspension in the US markets on September 17, 2012. Amoxicillin tablets (500 mg and 875 mg), capsules (250 mg and 500 mg) and Oral Suspension (125 mg/5ml, 200mg/5 ml and 400 mg/5ml) are approved by United States Food and Drug Administration (USFDA).
Dr Reddy’s Amoxicillin tablets in 500 mg and 875 mg are available in bottle counts of 20 and 100. Amoxicillin capsules in 250 mg and 500 mg are available in bottle counts of 100 and 500, while Amoxicillin oral suspension in 200 mg mg/5ml and 400 mg/5ml are available in bottle sizes of 50 ml, 75 ml and 100 ml.
The Amoxil brand and generic tablets (875 mg) has US sales of approximately $22.2 million. Out of which capsules have sales of approximately $67.2 million and oral suspension has US sales of approximately $89.5 million, all for the most twelve months ending June 2012, according to IMS Health.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1852.70 |
| Dr. Reddys Lab | 1275.40 |
| Cipla | 1298.60 |
| Zydus Lifesciences | 932.85 |
| Lupin | 2252.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: